https://www.cs.uci.edu/forbes-the-100-leading-pioneers-of-ai-drug-development-pierre-baldi-named




Forbes: “The 100 Leading Pioneers Of AI Drug Development” (Pierre Baldi named) 



 





































 this is a widget called second front page widget area

Explore

Contact Us


Faculty
Research

Research Areas
Research Centers


Graduate Degrees

Computer Science Programs
Current Graduate Students


Undergraduate Degrees
News  & Events

News
Seminar Series
Distinguished Lecture Series
Research Showcase


Apply Now

Undergraduate Admissions
Graduate Admissions
Faculty Candidates


Forbes: “The 100 Leading Pioneers Of AI Drug Development” (Pierre Baldi named)
February 19, 2019 
The profile of these people is quite interesting as 43% of them come from Academia. It seems that some of the big brains of the planet have targeted their efforts on improving human life and possibly extending the lifespan. The impact of AI leaders in this category is characterized by a high number of peer-reviewed publications, a high level of citation, pioneering roles in theoretical or engineering of ML/AI for drug discovery, a notable theoretical breakthrough, a technical invention, or a widely adopted commercial model.
Read the full story at Forbes.
« CPRI Receives $1.4M Gift for Securing the Seams of the Internet of EverythingABC: “Australian citizens are unwitting ‘combatants’ in cyberspace, Defence boss says” »

Latest news


Senior Spotlight: Tennis Player and CS Major Matthew Sah Serves Up Aces On and Off the Court
September 28, 2022


Register Today for the Southern California AI & Biomedicine Symposium
September 20, 2022


CPO Magazine: “A Legal View of New NIST Quantum-Resistant Algorithms” by Bryan Cunningham
September 19, 2022


UCI Ranked 24th in Undergraduate Computer Science Programs by U.S. News & World Report
September 16, 2022


Senior Spotlight: Jose Cisneros Builds Impressive Resume with Trio of Internships
September 15, 2022




 





© 2022 UC Regents
Feedback
Privacy Policy



 




